SCHEMBL4917405

SCHEMBL4917405

Cc1cc(O)n(-c2ccccc2Cl)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.50
PDE4B Q07343 1/20 0.43
GAA P10253 1/20 0.41
P2RY1 P47900 2/20 0.40
LMNA P02545 1/20 0.40
MAPK11 Q15759 1/20 0.40
MAPK14 Q16539 1/20 0.40
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
RIPK1 Q13546 1/20 0.39
OPRM1 P35372 1/20 0.39
ALDH1A1 P00352 2/20 0.39
POLB P06746 1/20 0.39
NOTUM Q6P988 1/20 0.39
TMEM97 Q5BJF2 1/20 0.39
SIGMAR1 Q99720 1/20 0.39
CYP1A2 P05177 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12528207 0.82 KDM4E (0.65) KDM4EGAALMNAMAPK11MAPK14
SCHEMBL4918738 0.82 ALDH1A1 (0.46) KDM4EGAALMNAMAPK11MAPK14
SCHEMBL17255733 0.82 KDM4E (0.47) KDM4EGAALMNANPC1RAB9A
SCHEMBL5807693 0.81 HTT (0.51) KDM4EGAALMNANPC1OPRM1
SCHEMBL11435978 0.81 LMNA (0.51) LMNANPC1OPRM1ALDH1A1
SCHEMBL1817147 0.79 CYP1A2 (0.59) KDM4EPDE4BLMNARAB9AOPRM1
SCHEMBL4917993 0.78 P2RY1 (0.46) KDM4EGAAP2RY1LMNAOPRM1
SCHEMBL28674190 0.78 PDE4B (0.45) KDM4EPDE4BGAAP2RY1LMNA
SCHEMBL28675292 0.78 ALDH1A1 (0.52) KDM4EPDE4BGAAP2RY1LMNA
SCHEMBL3676529 0.77 NPC1 (0.63) KDM4ELMNANPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269293-A1 PYRAZOLE DERIVATIVES AS ANTI-PLATELET AND ANTI-THROMBOTIC AGENTS PFIZER INC. 2008-10-30 US disclosed
WO-2008023235-A1 PYRAZOLE DERIVATIVES AS ANTI-PLATELET AND ANTI-THROMBOTIC AGENTS PFIZER PRODUCTS INC. (US) 2008-02-28 WO disclosed
US-4217272-A DYEING CELLULOSIC FIBERS STERLING DRUG INC. (US) 1980-08-12 US disclosed
US-4153598-A Monoazo and diazo colorants from aminoalkylanilines and bis(aminoalkyl)anilines STERLING DRUG INC. (US) 1979-05-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269293-A1 PYRAZOLE DERIVATIVES AS ANTI-PLATELET AND ANTI-THROMBOTIC AGENTS P2RY1, P2RY11, P2RX7 KDM4E 3700/4885PDE4B 341/4885GAA 3831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.